IsoPlexis vs Mission Bio

IsoPlexis logo

IsoPlexis

Powerful Biology Accelerating the Future of Medicine

65 employees · est. 2013 · Branford, United States

VS
Mission Bio logo

Mission Bio

The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution

88 employees · est. 2014 · South San Francisco, United...

IsoPlexis is the older company (2013 vs 2014).

Side-by-Side Comparison

IsoPlexis Mission Bio
Founded
2013 older 2014
Headquarters
Branford, United States South San Francisco, United States
Employees
65 88
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Clean Energy
Funding Stage
Series D Growth
Total Funding
$205.10M $186.50M
Funding Rounds
11 14
Services
Live Single Cell Functional Analysis, Optofluidic Instruments, Proteomic Barcoding Technology, Antibody Discovery Kits, Cell Line Development Kits, T Cell Profiling Kits, Software for Cell Analysis and Visualization Tapestri Platform, Single-cell Genomic Analysis, Precision Medicine Solutions, CRISPR Genotoxicity Mapping, Multi-omic Data Integration
Target Customers
Biotechnology Companies, Pharmaceutical Companies, Academic Researchers, Translational Researchers, Immunology Specialists, Oncology Researchers Cancer Researchers, Biotechnology Companies, Pharmaceutical Companies, Clinical Researchers, Genomic Scientists
Taxonomy
Life Science TechnologySingle-Cell DetectionImmune MedicineCurative MedicinesHigh Resolution SystemsTherapeutic Development +9 Single-cell Targeted DNA SequencingPrecision GenomicsDroplet MicrofluidicsSingle-cell Multi-omics PlatformBioinformatics SupportOncology Blood Cancers +9
Website
isoplexis.com missionbio.com
IsoPlexis logo

About IsoPlexis

IsoPlexis, founded in 2013, is a pioneering company in the fields of Biotechnology, Health Care, Health and Wellness, and Medical Devices. Headquartered in the United States, IsoPlexis is at the forefront of transforming immune medicine with their innovative, high-resolution systems designed to enha...

Mission Bio logo

About Mission Bio

Mission Bio, founded in 2014, is a key player in the Biotechnology and Health Care industries, with a focus also on Clean Energy. Headquartered in the United States, the company has carved a niche with its Tapestri® Platform, the only technology that delivers single-cell targeted DNA sequencing at s...

Also comparing in this category

Comparing more than these two?

Get IsoPlexis, Mission Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does IsoPlexis compare?

A PDF of IsoPlexis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

IsoPlexis was founded in 2013, based in Branford, United States, with 65 employees. IsoPlexis, founded in 2013, is a pioneering company in the fields of Biotechnology, Health Care, Health and Wellness, and Medical Devices. Headquartered in the United States, IsoPlexis is at the foref. Mission Bio was founded in 2014, based in South San Francisco, United States, with 88 employees. Mission Bio, founded in 2014, is a key player in the Biotechnology and Health Care industries, with a focus also on Clean Energy. Headquartered in the United States, the company has carved a niche wit.
IsoPlexis has raised $205.10M and Mission Bio $186.50M. Latest stage: IsoPlexis Series D, Mission Bio Growth.
Both work in Biotechnology and Health Care.

Compare IsoPlexis with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at IsoPlexis on 15 Jun 2026, and Mission Bio on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes